Labiotech.eu

More News! 18 Sep 2019

€15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II

Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for late-stage liver cirrhosis to a phase IIa trial. The money will finance the completion of an ongoing phase I trial of Versantis’ lead candidate for the condition decompensated liver cirrhosis. Following this, the company will use the funds to launch […]

September 18, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 17 Sep 2019

UK Biotech to Fight Antibiotic-Resistant Bacteria with €8M Grant

The UK biotech Procarta Biosystems has received a grant worth up to €8.3M from the nonprofit US partnership CARB-X to develop drugs that kill antibiotic-resistant pathogens while sparing benign bacteria in the gut. The total funding includes €2M upfront and up to an extra €6.3M that Procarta will receive if it hits unspecified milestones. Procarta […]

September 17, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Sep 2019

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm

Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis at a conference in Stockholm. The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered experts and companies working on multiple sclerosis in Sweden this year. Companies such as Genmab and GeNeuro revealed the progress of their treatments, […]

September 17, 2019 - 4 minutesmins - By Jonathan Smith

sepsis diagnosis abionic blood infection

News and Trends 16 Sep 2019

Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test

A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict within just five minutes which intensive care patients are likely to develop sepsis in a clinical study. In the pivotal study, Abionic trialed the blood test in 300 intensive care patients with a high risk of sepsis. Abionic found that […]

September 16, 2019 - 3 minutesmins - By Jonathan Smith

deCODE genetics whole genome sequencing uk biobank

News and Trends 13 Sep 2019

Icelandic Company to Sequence 225,000 Genomes from UK Patients

The Icelandic genomics company deCODE genetics has joined the UK’s Wellcome Sanger Institute in sequencing 450,000 genomes as part of a massive €224M (£200M) project organized by the UK Biobank initiative. The UK Biobank’s €224M grant includes €56M (£50M) from the UK government, €56M from the UK’s Wellcome Trust charity, and €112M (£100M) from big […]

September 13, 2019 - 3 minutesmins - By Jonathan Smith

Startup Scout 13 Sep 2019

This Biotech Makes Meat Substitutes from Crops Using Fungi

We’re traveling to Glasgow, UK, this week. The biotech 3F BIO is using fungi to convert plant sugars into proteins in a process that uses less than half of the water and feed that farming animal meat requires. Mission: To turn plant sugars into proteins using fungi, which could help to feed the growing world’s […]

September 13, 2019 - 4 minutesmins - By Jonathan Smith

Inside Labiotech 12 Sep 2019

Prost🍺! Labiotech is the Main Media Partner of the 25th Edition of BIO-Europe!

This is an extraordinary year for BIO-Europe, because it’s celebrating its 25th anniversary. Congratulations! 🎉 As Europe’s biggest biotech event, Bio-Europe attracted 4,300+ attendees from 2,300+ companies in 2018. What’s even more amazing is that they helped coordinate over 26,000 meetings where biotech professionals gathered around to partner with each other and foster innovation. Labiotech […]

September 12, 2019 - 3 minutesmins - By Yi-Jen Chang

More News! 12 Sep 2019

French Biotech to Develop Septic Shock Therapy with €39M Series B

The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug nangibotide, expected to start in November this year. […]

September 12, 2019 - 3 minutesmins - By Jonathan Smith

Expert Advice 12 Sep 2019

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

Although it’s becoming increasingly popular in life science marketing, branded content is still in its infancy. This does not mean it isn’t worth investing in. Quite the contrary: because it is fairly new, it is all the more exciting and can reach promising audiences within the life sciences industry. While other industries have long since […]

September 12, 2019 - 12 minutesmins - By Larissa Warneck-Silvestrin

More News! 11 Sep 2019

Dutch Company Raises €60M to Treat Inherited Inflammatory Disease

The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […]

September 11, 2019 - 2 minutesmins - By Jonathan Smith

Switzerland Hôpitaux Universitaires Genève HUG

News and Trends 11 Sep 2019

IBM’s Watson for Genomics Launches in First European Hospital

The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […]

September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

grunenthal mesoblast chronic low back pain

News and Trends 11 Sep 2019

Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back pain from the Australian biotech Mesoblast in a deal that could be worth over €900M. Under the terms of the deal, Grünenthal will gain exclusive rights to commercialize Mesoblast’s cell therapy for chronic low back pain in Europe and Latin […]

September 11, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

€15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II

UK Biotech to Fight Antibiotic-Resistant Bacteria with €8M Grant

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm

Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test

Icelandic Company to Sequence 225,000 Genomes from UK Patients

This Biotech Makes Meat Substitutes from Crops Using Fungi

Prost🍺! Labiotech is the Main Media Partner of the 25th Edition of BIO-Europe!

French Biotech to Develop Septic Shock Therapy with €39M Series B

Interview: The Do’s & Don’ts of Branded Content in the Life Sciences Industry

Dutch Company Raises €60M to Treat Inherited Inflammatory Disease

IBM’s Watson for Genomics Launches in First European Hospital

Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!